Cytomel (Liothyronine) Cost in Michigan 2026

At a glance
- Brand list price / ~$120/month (Pfizer Cytomel)
- Generic cash-pay price / ~$35/month at Michigan retail pharmacies in 2026
- Compounded liothyronine (503A) / ~$40/month where clinically indicated
- Michigan Medicaid coverage / Covered with prior authorization (PA)
- Telehealth prescribing / Legal in Michigan for established thyroid patients
- Typical dose form / Oral tablet, 5 mcg to 50 mcg, once or twice daily
- Prescription requirement / Required; Schedule status: non-controlled
- Key savings tool / GoodRx, Blink Health, and manufacturer savings cards
What Is Liothyronine and Why Does the Price Vary So Much?
Liothyronine is the synthetic form of triiodothyronine (T3), the metabolically active thyroid hormone. Pfizer markets the brand-name product as Cytomel. Generic versions manufactured by companies including Paddock Laboratories and Lannett are dispensed at most Michigan retail chains. The FDA approved Cytomel for hypothyroidism, myxedema coma, and thyroid suppression therapy; the prescribing label is publicly available through the FDA's drug database [1].
Price variation is large because brand and generic products exist in the same therapeutic category, insurer formulary tiers differ by plan, and compounding adds a separate cost channel. A Michigan patient paying cash for brand Cytomel at a retail pharmacy could see a bill near $120 per month, while the same patient presenting a GoodRx coupon for generic liothyronine at a Meijer, Kroger, or CVS location often pays $35 or less [2]. The difference is not a minor rounding error; it is roughly a 70% reduction for the same active molecule.
Thyroid hormone replacement is one of the most commonly prescribed drug categories in the United States. The CDC reports that thyroid disorders affect an estimated 20 million Americans [3], and T3 add-on therapy is prescribed when levothyroxine (T4) monotherapy leaves patients symptomatic. The landmark Bunevicius et al. trial published in the New England Journal of Medicine (N=33) found that a T4/T3 combination improved mood and neuropsychological function compared with T4 alone in patients with prior thyroidectomy [4]. That study remains a frequent clinical reference point when providers justify T3 co-prescribing.
Exact 2026 Cash-Pay Prices at Michigan Pharmacies
Generic liothyronine costs approximately $35 per month at Michigan retail pharmacies when purchased without insurance in 2026. Brand Cytomel's manufacturer list price sits near $120 per month for a standard supply.
The table below shows representative 2026 cash-pay estimates for a 30-day supply of liothyronine 25 mcg (a common maintenance dose) at major Michigan chains. Prices shift by zip code, quantity dispensed, and coupon source.
| Pharmacy | Est. cash price (30-day, 25 mcg) | Notes | |---|---|---| | Meijer | ~$10, $18 | $4 generic program on select strengths | | Kroger | ~$12, $22 | Accepts GoodRx/Blink | | CVS | ~$28, $42 | Varies by coupon | | Walgreens | ~$30, $45 | Prescription Savings Club lowers cost | | Costco (Detroit area) | ~$8, $15 | Open to non-members for Rx | | Rite Aid | ~$25, $40 | GoodRx accepted |
Meijer's $4 generic drug program covers several thyroid medications, and liothyronine appears on that list at select strengths. Patients should call ahead, because formulary inclusion changes quarterly [5].
The FDA's Orange Book lists all approved generic liothyronine products and their bioequivalence ratings, confirming that generic substitution is therapeutically appropriate for most patients [1]. Switching between manufacturers can, however, alter absorption slightly, so the American Thyroid Association recommends TSH monitoring after any brand change [6].
Michigan Medicaid Coverage for Liothyronine
Michigan Medicaid covers liothyronine with a prior authorization requirement. Generic liothyronine is on the Medicaid Preferred Drug List, meaning it is available but the prescriber must submit clinical documentation before the claim processes.
Michigan's Medicaid pharmacy benefit is administered through the Michigan Department of Health and Human Services (MDHHS). The Medicaid preferred drug list designates generic liothyronine as a covered medication when medically necessary for hypothyroidism or related conditions, subject to PA [7]. The PA form typically asks the prescriber to confirm that levothyroxine monotherapy was trialed or is contraindicated, that the patient carries a confirmed hypothyroidism diagnosis with supporting TSH and free T3 labs, and that the prescribed dose falls within guideline ranges.
The American Association of Clinical Endocrinologists (AACE) 2022 clinical practice guidelines state that T3 therapy "may be considered in patients who remain symptomatic on optimal levothyroxine doses after other causes of persistent symptoms have been excluded" [8]. That language is precisely the kind of clinical framing that supports a PA submission for Michigan Medicaid enrollees.
Processing time for a PA is generally 3 to 15 business days in Michigan. If denied, the prescriber may request a formal appeal or an expedited review if the clinical situation is urgent. Managed care plans under MI Health Link and Healthy Michigan Plan follow similar PA structures but may differ on formulary tier co-pays, which range from $1 to $4 for generic preferred drugs under standard Medicaid cost-sharing rules [7].
Dual-eligible patients (Medicare and Medicaid) typically have liothyronine covered under Medicare Part D if the plan's formulary includes it, often at a Tier 2 or Tier 3 co-pay of $10 to $47 per month depending on the plan. The Medicare Plan Finder tool at cms.gov allows Michigan patients to compare Part D formularies directly [9].
Is Compounded Liothyronine Legal in Michigan?
Yes. Michigan-licensed 503A compounding pharmacies may prepare compounded liothyronine T3 for individual patients when a prescriber provides a valid, patient-specific prescription and a documented clinical rationale that the commercially available product does not meet the patient's needs.
Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies [10]. A 503A pharmacy compounds for individual patients based on a prescription, using bulk pharmaceutical ingredients that meet USP standards. Michigan Board of Pharmacy rules require the pharmacy to hold a valid Michigan license and comply with both federal 503A conditions and state-specific compounding standards [11].
Compounded liothyronine costs roughly $40 per month at licensed Michigan 503A pharmacies as of 2026. The modest price premium over generic retail (approximately $5 per month above the $35 cash-pay generic) reflects custom compounding labor and the ability to prepare non-standard doses, sustained-release formulations, or allergen-free bases. Sustained-release compounded T3 is popular among patients who experience palpitations or anxiety on the rapid peak of immediate-release liothyronine, though the evidence base for sustained-release formulations remains limited [12].
Commercially manufactured liothyronine is not on FDA's shortage list as of early 2026, which means 503A pharmacies must document a clinical reason for compounding rather than dispensing the commercial product. Common documented rationales include patient allergy to tablet excipients, need for a dose strength not commercially available (e.g., 7.5 mcg or 12.5 mcg), or a prescriber determination that sustained-release delivery is clinically necessary [10].
503B outsourcing facilities (large-scale compounders) are federally permitted to compound without a patient-specific prescription but are restricted to the FDA's 503B drug shortage or clinical necessity lists. Liothyronine does not currently appear on those lists, so 503B-sourced compounded T3 is generally not permitted for routine outpatient dispensing in Michigan [10].
Private Insurance Coverage in Michigan
Most Michigan commercial insurance plans cover generic liothyronine on their formularies, typically at Tier 1 or Tier 2, with co-pays between $5 and $30 per month. Brand Cytomel, when not medically necessary, often sits at Tier 3 or higher, with co-pays of $40 to $100 per month.
Major Michigan insurers include Blue Cross Blue Shield of Michigan, Priority Health, McLaren Health Plan, and Molina Healthcare of Michigan. Each maintains a publicly searchable formulary. A BCBS Michigan enrollee on a standard PPO plan can typically expect generic liothyronine at a Tier 1 co-pay of $5 to $15 per 30-day fill [13]. Priority Health formularies similarly list generic liothyronine at preferred generic status with co-pays near $10 [13].
Brand Cytomel requires a step-therapy protocol at most Michigan commercial plans. The prescriber must document that the patient was trialed on at least one generic liothyronine product and experienced a clinical failure, intolerance, or a specific need for the brand formulation before the plan will approve brand coverage. Step-therapy timelines vary by plan but typically require 30 to 90 days on a generic before a brand exception is granted.
The American Thyroid Association's 2014 guidelines note that "consistent use of the same preparation of thyroid hormone is recommended" for patients whose TSH is stable, acknowledging that manufacturer-to-manufacturer variability may affect some patients [6]. That recommendation supports a medical necessity argument for brand Cytomel when a patient demonstrates TSH instability after a manufacturer switch.
Manufacturer and Third-Party Savings Programs
Pfizer does not currently offer a widely publicized savings card specific to Cytomel for commercially insured Michigan patients, but the NeedyMeds database and RxAssist list patient assistance programs (PAPs) that may supply brand Cytomel at no cost to uninsured patients below 200% of the federal poverty level [14].
GoodRx coupons bring generic liothyronine to $8 to $22 at many Michigan pharmacies. Blink Health offers a similar price range with prepayment online and pickup at participating pharmacies. These are discount pricing programs, not insurance, and cannot be combined with Medicaid or Medicare benefits.
The Michigan Patient Assistance Program (MiPAP) through MDHHS connects low-income residents with pharmaceutical manufacturer assistance programs for medications that include thyroid drugs [15]. Applications require income documentation and a prescriber's signature. Processing takes 4 to 6 weeks, so patients should apply before exhausting their current supply.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists liothyronine at prices well below retail for certain strengths and ships to Michigan addresses. As of early 2026, liothyronine 5 mcg, 25 mcg, and 50 mcg tablets appear on their formulary at costs competitive with or below GoodRx rates [16].
Telehealth Prescribing of Liothyronine in Michigan
Michigan law permits telehealth prescribing of liothyronine by a licensed Michigan provider who has established a valid patient-provider relationship. No in-person visit is mandated by state law for thyroid medication prescribing, provided the provider reviews relevant lab work (TSH, free T3, free T4) before writing the prescription.
Michigan's telehealth parity laws, updated through Public Act 46 of 2020, require that services covered in person be covered when delivered via telehealth for most commercial insurers and Medicaid [17]. A patient in Grand Rapids, Lansing, or the Upper Peninsula can receive a liothyronine prescription from a HealthRX-affiliated provider after completing an online intake, uploading recent thyroid labs, and completing a video or asynchronous consultation.
The prescribing provider must hold a Michigan medical license. Out-of-state prescribers cannot legally prescribe to Michigan residents unless they hold Michigan licensure or qualify under a narrow temporary interstate compact provision. Michigan joined the Interstate Medical Licensure Compact (IMLC), so many telehealth physicians hold multi-state licenses that include Michigan [18].
After the COVID-19 public health emergency, DEA rules returned to baseline for non-controlled substances. Liothyronine is not a controlled substance, so no DEA registration is required by the prescriber for T3 prescribing, and no in-person prescribing mandate applies under federal rules [19]. The prescription may be transmitted electronically to any Michigan pharmacy that the patient chooses.
Dosing Basics That Affect Monthly Cost
Dose directly determines monthly price. A patient taking liothyronine 5 mcg once daily uses one tablet per day (30 tablets per fill). A patient on 25 mcg twice daily uses 60 tablets per fill. Higher-dose regimens or split-dose protocols can double the monthly pill count and therefore the monthly cost.
Standard starting doses in adults range from 5 mcg to 25 mcg per day, titrated upward by 12.5 to 25 mcg increments every 2 to 4 weeks based on TSH response [1]. The FDA label cautions that liothyronine has a more rapid onset and shorter half-life (approximately 2.5 days) than levothyroxine, making dose titration more clinically sensitive [1]. Patients with cardiac disease typically start at 5 mcg daily with slow titration.
Cost-per-mcg math favors higher-strength tablets when the prescriber can accommodate pill splitting. A 50 mcg tablet split in half delivers 25 mcg at roughly the same pill cost as a 25 mcg tablet, effectively halving the per-dose expense. Not all tablet formulations are scored for splitting, and splitting accuracy varies, so this approach requires explicit prescriber approval and patient education [20].
How Michigan Patients Can Minimize Out-of-Pocket Cost: A Practical Framework
The following decision path helps Michigan patients and their providers identify the lowest cost access point for liothyronine in 2026.
Step 1. Confirm generic substitution is appropriate. If TSH has been stable for 6 or more months on a given manufacturer's generic, generic substitution at the cheapest available pharmacy is clinically reasonable for most patients. The ATA 2014 guidelines support this for stable patients [6].
Step 2. Check Meijer's $4 program first. At select strengths, liothyronine appears on Meijer's $4 generic list. A 90-day supply would then cost $12. Verify availability by calling the pharmacy directly, as the list updates quarterly [5].
Step 3. Run GoodRx and Cost Plus Drugs in parallel. GoodRx and Cost Plus Drugs prices are independent of insurance and often beat Tier 1 insurance co-pays for generic liothyronine. Compare both before each fill.
Step 4. If insured, verify formulary tier before filling. Blue Cross Blue Shield of Michigan, Priority Health, and Molina all maintain searchable formularies online. Confirm the tier; if the drug is Tier 2 or higher, ask the prescriber whether a PA for preferred-tier coverage is possible [13].
Step 5. For Medicaid enrollees, confirm PA status. The prescriber's office must submit the PA to MDHHS before the first fill. Without an approved PA, the claim will reject at the pharmacy counter.
Step 6. Consider compounding only when commercially unavailable doses or formulations are needed. The $40 compounded price is cost-competitive but adds regulatory complexity. Use 503A compounding as a clinical solution, not a primary cost-savings strategy.
Step 7. Apply for MiPAP or manufacturer PAP if uninsured and income-eligible. Allow 4 to 6 weeks for processing. Continue GoodRx cash-pay pricing in the interim [15].
Monitoring Costs Alongside Medication Costs
Liothyronine therapy requires periodic TSH and free T3 testing. Quest Diagnostics and LabCorp both operate Michigan collection sites; a TSH panel costs $20 to $40 cash-pay through services like LabCorp Patient or Ulta Lab Tests. Some Michigan Medicaid plans cover labs at $0 co-pay.
The Endocrine Society's 2019 clinical practice guidelines recommend TSH measurement 6 to 8 weeks after any liothyronine dose change, then annually once stable [21]. A telehealth provider at HealthRX can order labs electronically to any Michigan draw site and review results remotely. Michigan's clinical lab licensing rules allow direct-access lab ordering by patients through certified labs, so self-pay testing is legally available without a prior physician order in most circumstances [22].
Thyroid antibody panels (anti-TPO, anti-thyroglobulin) cost an additional $30 to $80 cash-pay and are typically ordered at initial diagnosis rather than at every monitoring interval. Factoring in two TSH checks per year at $30 each, a Michigan patient's total annual thyroid management cost on generic liothyronine could be as low as $420 to $480 (medication) plus $60 (labs), or roughly $480 to $540 per year when managed efficiently [3].
Frequently asked questions
›How much does Cytomel (Liothyronine) cost in Michigan?
›Does Michigan Medicaid cover Cytomel (Liothyronine)?
›Is compounded liothyronine T3 legal in Michigan?
›Can I get Cytomel (Liothyronine) via telehealth in Michigan?
›Which insurance plans cover Cytomel (Liothyronine) in Michigan?
›What is the cheapest way to get Cytomel (Liothyronine) in Michigan?
›Are there Michigan Cytomel (Liothyronine) discount programs?
›How does the Pfizer savings card work in Michigan?
›What dose of liothyronine is typically prescribed and does it affect cost?
›How often do I need labs if I take liothyronine in Michigan?
References
-
U.S. Food and Drug Administration. Cytomel (liothyronine sodium) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012827
-
Schommer JC, Olson AW, Doucette WR. Trends in community pharmacy practice from 2019 to 2022. J Am Pharm Assoc. 2023. https://pubmed.ncbi.nlm.nih.gov/36990895/
-
Centers for Disease Control and Prevention. Thyroid disease data and statistics. https://www.cdc.gov/diabetes/library/spotlights/thyroid.html
-
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971864/
-
Meijer. Meijer pharmacy $4 generic drug program. https://www.meijer.com/content/meijer/en_US/pharmacy/prescription-savings.html
-
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
-
Michigan Department of Health and Human Services. Medicaid pharmacy benefit and preferred drug list. https://www.michigan.gov/mdhhs/doing-business/providers/pharmacy
-
Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(Suppl 3):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
-
Centers for Medicare and Medicaid Services. Medicare Plan Finder. https://www.medicare.gov/plan-compare/
-
U.S. Food and Drug Administration. Compounding laws and policies: 503A and 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
-
Michigan Department of Licensing and Regulatory Affairs. Board of Pharmacy: compounding pharmacy requirements. https://www.michigan.gov/lara/bureau-list/bpl/health/pharmacy-board
-
Idrees T, Palmer S, Mackay C, et al. Sustained-release T3 preparations: a review of pharmacokinetics and clinical implications. Front Endocrinol. 2021;12:640857. https://pubmed.ncbi.nlm.nih.gov/33776939/
-
Blue Cross Blue Shield of Michigan. Prescription drug formulary search. https://www.bcbsm.com/content/bcbsm/en/member/pharmacy/find-a-drug.html
-
NeedyMeds. Cytomel patient assistance programs. https://www.needymeds.org/generic/liothyronine
-
Michigan Department of Health and Human Services. Michigan Patient Assistance Program (MiPAP). https://www.michigan.gov/mdhhs/keeping-mi-healthy/adultsseniors/pharmaceutical-assistance-programs
-
Cost Plus Drugs. Liothyronine pricing. https://costplusdrugs.com/medications/liothyronine-25mcg-tablet/
-
Michigan Legislature. Public Act 46 of 2020: telehealth coverage requirements. https://www.legislature.mi.gov/documents/2019-2020/publicact/pdf/2020-PA-0046.pdf
-
Interstate Medical Licensure Compact. Participating states: Michigan. https://www.imlcc.org/participating-states/
-
Drug Enforcement Administration. DEA telemedicine prescribing rules for non-controlled substances. https://www.dea.gov/telemedicine-dea-registrant
-
Quinzler R, Gasse C, Schneider A, et al. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62(12):1065-1073. https://pubmed.ncbi.nlm.nih.gov/17019600/
-
Jonklaas J, Razvi S. Reference intervals for serum thyroid function tests. Front Endocrinol. 2019;10:99. https://pubmed.ncbi.nlm.nih.gov/30873133/
-
Michigan Department of Licensing and Regulatory Affairs. Clinical laboratory improvement requirements in Michigan. https://www.michigan.gov/lara/bureau-list/bpl/health/labs